Bill > AB8

This bill introduces comprehensive changes to California's cannabis, industrial hemp, and related regulatory frameworks, with key provisions spanning multiple areas. Beginning January 1, 2026, the bill will prohibit industrial hemp raw extract from being incorporated into food, food additives, beverages, or dietary supplements unless the extract contains CBD or CBN isolate with over 99 percent purity and no tetrahydrocannabinols or synthetic cannabinoids. The legislation narrows the definition of industrial hemp, subjects industrial hemp entering the licensed cannabis market to strict regulatory requirements, and establishes new testing, packaging, and labeling standards. The bill also prohibits the sale of hemp flower, hemp prerolls, inhalable cannabis products derived from industrial hemp, cannabis products manufactured outside the licensed market, and products containing synthetic cannabinoids. Additionally, the legislation imposes new restrictions on advertising and marketing of industrial hemp products, requires comprehensive tracking and tracing of cannabis and hemp products, and introduces enhanced enforcement mechanisms for state and local agencies. These changes aim to improve consumer safety, regulate the rapidly evolving cannabis and hemp industries, and create more stringent standards for product development, testing, and distribution, with most provisions becoming fully operative on January 1, 2028.

Budget and Finance, Business and Industry

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB8